By selling these assets, UnitedHealth (UNH) and Amedisys aim to avoid potential monopoly issues and ensure a smoother merger process.

Oppenheimer Asset Management is bullish on UnitedHealth Group (UNH) stock, predicting a rise to $650.

UNH was among dozens of colleges and universities that S&P downgraded from “stable” to “negative” last April due to the unknown financial impact of the pandemic.

Nigeria has declined to approve the sale of Shell's (NYSE:SHEL) onshore and shallow-water oil and gas in the Niger Delta region to a consortium of local companies, the country's upstream regulator ...

DURHAM — Company leaders who want to address their social and environmental impact can receive help from University of New Hampshire students through a new partnership between the college and ...

UnitedHealth (NYSE:UNH) faced several challenges in the year that affected its share price, which included its subsidiary, Charge Healthcare, experiencing a cyber attack in mid-February that ...

U.S. oil and gas companies could face an uphill struggle to sell about $27 billion of assets to fund investor payouts over the next few years as the biggest wave of energy megamergers in 25 years ...

Health insurance company UnitedHealth (NYSE:UNH) in Q1 CY2025, but sales rose 9.8% year on year to $109.6 billion. Its non-GAAP profit of $7.20 per share was 1.3% below analysts’ consensus ...

UnitedHealth (UNH) beat Street forecasts for Q4 2022 financials on Friday, posting better than expected medical costs despite concerns over respiratory viruses. Read the full story here.

UnitedHealth Group Incorporated UNH and Amedisys, Inc.’s AMED $3.3 billion merger is set to close in the second half of 2024, with Amedisys becoming a wholly-owned subsidiary of UnitedHealth ...